Cardiex Limited (December 2024)
Blackpeak is pleased to announce that it acted as joint lead manager to Cardiex Limited (ASX.CDX) $3.25 million placement. Cardiex is a digital health technology company specialising in non-invasive cardiovascular health monitoring solutions.
The Company’s suite of products includes medical & home health devices, digital solutions for hypertension, cardiovascular disease, and other vascular health disorders – all based on the Company’s market leading SphygmoCor® vascular biomarker technology. Strategically positioned for transformative growth, Cardiex’s new FDA-cleared flagship product, the CONNEQT Pulse, and an expanding portfolio of innovative health technologies provide substantial opportunities in maternal health, cardiology, and preventative care.
We look forward to supporting Cardiex on its CONNEQT Pulse US launch and its ongoing growth journey.
Below is a link to the ASX announcement from CardieX: